GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Institute Of Advanced Medicine Holdings Ltd (SGX:9G2) » Definitions » Cash Ratio

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Cash Ratio : 0.32 (As of Jun. 2022)


View and export this data going back to 2024. Start your Free Trial

What is Singapore Institute Of Advanced Medicine Holdings Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Singapore Institute Of Advanced Medicine Holdings's Cash Ratio for the quarter that ended in Jun. 2022 was 0.32.

Singapore Institute Of Advanced Medicine Holdings has a Cash Ratio of 0.32. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Singapore Institute Of Advanced Medicine Holdings's Cash Ratio or its related term are showing as below:

SGX:9G2' s Cash Ratio Range Over the Past 10 Years
Min: 0.32   Med: 0.32   Max: 0.48
Current: 0.48

During the past 3 years, Singapore Institute Of Advanced Medicine Holdings's highest Cash Ratio was 0.48. The lowest was 0.32. And the median was 0.32.

SGX:9G2's Cash Ratio is ranked worse than
51.52% of 656 companies
in the Healthcare Providers & Services industry
Industry Median: 0.5 vs SGX:9G2: 0.48

Singapore Institute Of Advanced Medicine Holdings Cash Ratio Historical Data

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore Institute Of Advanced Medicine Holdings Cash Ratio Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23
Cash Ratio
0.32 0.32 0.48

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23
Cash Ratio 0.32 0.32 0.48

Competitive Comparison of Singapore Institute Of Advanced Medicine Holdings's Cash Ratio

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore Institute Of Advanced Medicine Holdings's Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's Cash Ratio falls into.



Singapore Institute Of Advanced Medicine Holdings Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Singapore Institute Of Advanced Medicine Holdings's Cash Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash Ratio (A: Jun. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=11.051/22.816
=0.48

Singapore Institute Of Advanced Medicine Holdings's Cash Ratio for the quarter that ended in Jun. 2022 is calculated as:

Cash Ratio (Q: Jun. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=15.839/50.128
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Singapore Institute Of Advanced Medicine Holdings Cash Ratio Related Terms

Thank you for viewing the detailed overview of Singapore Institute Of Advanced Medicine Holdings's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Singapore Institute Of Advanced Medicine Holdings Ltd is a healthcare service provider using advanced technology for early and accurate diagnosis, It is engaged in the following business segments Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services. Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services. Maximum revenue is generated from generated from Medical Diagnostics and Treatments.

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Headlines

No Headlines